Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1692234 Seattle, WA
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$5,634,764
-$4,601,941 QoQ
Shares Held
89,526
-38.6% QoQ
Ownership
0.204%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#62
of 256 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. TARS ranks #54 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in TARS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,634,764 89,526
2026-03-31 $10,236,705 145,926
2025-12-31 $12,589,864 153,760
2025-09-30 $8,815,190 148,329
2025-06-30 $5,883,671 145,240
2025-03-31 $6,915,273 134,617
2024-12-31 $119,986 2,167
2024-09-30 $69,430 2,111
2024-06-30 $2,062,306 75,876
2024-03-31 $1,091,807 30,036
2023-12-31 $1,559 77
2023-09-30 $444 25
2023-06-30 $451 25
2023-03-31 $314 25